News
4317 posts · page 1 of 180
Molbio Diagnostics Reports Rs 52.7 Crore Q1 Profit After IPO Launch
Molbio Diagnostics turned a Rs 23.94 crore loss into a Rs 52.7 crore profit in Q1, fueled by Truenat test-kit sales.
Indian AI Cancer Care Platform Highlighted in BRICS Health Journal
iOncology.ai, developed by AIIMS and C-DAC, gains recognition at the BRICS Summit for its potential in cancer care.
Waystar Weighs Sale Amid Stock Slump and AI Concerns
Waystar explores potential sale, hiring Evercore for guidance amid stock dip and AI market pressures.
GE HealthCare Eyes $1B Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, enhancing its diagnostics division.
Molbio Diagnostics Achieves Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, reversing last year's loss, fueled by Truenat test-kit sales.
Indian AI Platform iOncology.ai Shines in BRICS Health Journal
iOncology.ai, an AI cancer care platform from India, gains global attention at the BRICS Summit.
Waystar Considers Strategic Options, Including Potential Sale
Waystar is exploring a possible sale, returning it to private ownership, amid a 24% share price drop.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is in advanced talks to acquire Sofie Biosciences for $1 billion, enhancing its cancer scan capabilities.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, reversing last year's loss, following a successful IPO and rising demand for Truenat test kits.
Indian AI Cancer Platform iOncology.ai Gains Global Attention at BRICS Summit
iOncology.ai, developed by AIIMS and C-DAC, featured in BRICS Health Journal, aims to enhance cancer care in emerging economies.
Waystar Weighs Sale as Market Value Drops Amid Software Sector Slump
Waystar is exploring a potential sale, two years after its public listing, as its market value dips to $4.8 billion.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, enhancing its diagnostic capabilities.
Surge in Mumps Cases: CDC Reports Rising Outbreaks Nationwide
The CDC reports an alarming increase in mumps cases across the U.S., urging vaccination efforts.
BRICS Nations Push for Enhanced Disease Surveillance and Medical Regulation
Leaders from BRICS nations advocate for stronger collaboration in disease monitoring and medical product regulation.
ICAR-CIFRI Initiates Shrimp Disease Surveillance in Purba Medinipur
ICAR-CIFRI has launched a disease surveillance program in Purba Medinipur following a significant mortality event among whiteleg shrimp.
ICMR's Syndromic Surveillance: Detecting Outbreaks Early
ICMR's syndromic surveillance system aims to identify potential outbreaks early, ensuring rapid response to emerging health threats.
Brazil's Battle Against Dengue and Chikungunya: New Surveillance Data
Brazil leverages digital and epidemiological data to track dengue, chikungunya, and SARI, revealing key health insights.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO Success
Molbio Diagnostics has posted a Rs 52.7 crore profit for Q1, reversing last year's loss, amid strong Truenat test-kit sales.
iOncology.ai: Indian AI Cancer Care Platform Gains Global Attention
iOncology.ai, an AI platform for cancer care by AIIMS and C-DAC, is spotlighted in the BRICS Health Journal.
Waystar Weighs Sale Amid Software Sector Challenges
Waystar, a healthcare software firm, considers a sale following a stock decline, insiders say.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences, enhancing its diagnostics division.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 After IPO
Molbio Diagnostics announced a Rs 52.74 crore profit in Q1, rebounding from last year’s loss, following its successful IPO.
Indian AI Platform for Cancer Care Gains Spotlight at BRICS Summit
iOncology.ai, developed by AIIMS and C-DAC, features in BRICS Health Journal, highlighting AI's potential in cancer care.
Waystar Considers Sale Amid Stock Decline, Sources Reveal
Healthcare software firm Waystar is exploring a potential sale following a significant stock decline, sources say.